Zafgen (ZFGN) Tops Q1 EPS by 5c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/7/2026

1. MRVL
2. ZS
3. PENG
4. STZ
5. SKYD
6. HALO
7. BBIO
8. SPY
9. RCKT
10. CRWV

Go back to Zafgen (ZFGN) Tops Q1 EPS by 5c

Zafgen Reports First Quarter 2015 Financial Results

May 12, 2015 4:00 PM EDT

Quarter Highlighted by Accelerated Enrollment in bestPWS Clinical Trial - Six Month Data Now Expected in Early Q1 2016

Company on Track to Report Data from Ongoing ZAF-203 Clinical Trial in Late 2015/Very Early 2016

Ends Quarter with Cash and Marketable Securities of $234 Million Following Recent Follow-on Offering

BOSTON, May 12, 2015 (GLOBE NEWSWIRE) -- Zafgen, Inc. (Nasdaq: ZFGN), a biopharmaceutical company dedicated to significantly improving the health and well-being of patients affected by obesity and complex metabolic disorders, today announced its first quarter 2015 financial results.

... More